| UHC Medicaid Medical & Drug | Molecular Oncology Testing for Solid Tumor Cancer Diagnosis, Prognosis, and Treatment Decisions – Community Plan Medical Policy | 2026-02-01 |
| UHC Medicaid Medical & Drug | Noncontact Warming Therapy, Ultrasound Therapy, and Fluorescence Imaging for Wounds – Community Plan Medical Policy | 2026-02-01 |
| UHC Medicaid Medical & Drug | Omnibus Codes – Community Plan Medical Policy | 2026-02-01 |
| UHC Medicaid Medical & Drug | Percutaneous Patent Foramen Ovale (PFO) Closure – Community Plan Medical Policy | 2026-02-01 |
| UHC Medicaid Medical & Drug | Plagiocephaly and Craniosynostosis Treatment – Community Plan Medical Policy | 2026-02-01 |
| UHC Medicaid Medical & Drug | Prolotherapy and Platelet Rich Plasma Therapies – Community Plan Medical Policy | 2026-02-01 |
| UHC Medicaid Medical & Drug | Sleep Studies – Community Plan Medical Policy | 2026-02-01 |
| UHC Medicaid Medical & Drug | Stereotactic Body Radiation Therapy and Stereotactic Radiosurgery – Community Plan Medical Policy | 2026-02-01 |
| UHC Medicaid Medical & Drug | Surgery for the Prevention and Treatment of Lymphedema – Community Plan Medical Policy | 2026-02-01 |
| UHC Medicaid Medical & Drug | Visual Information Processing Evaluation and Orthoptic and Vision Therapy – Community Plan Medical Policy | 2026-02-01 |